(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLEARTHERAPY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLEARTHERAPY

ST13

US500000085038936

Class

3

Filing

85038936

Registration

4010246

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

05/03/2023

Trademark type

Word

Nice classes

3

Filing date

05/14/2010

Registration date

08/09/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/19/2022

Last transaction

04/07/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/09/2010

First use in commerce

07/09/2010

Drawing code

4

Owner type

16

Owner location

HOLLYWOOD,, FL, US

Examiner

CAPSHAW, DANIEL

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

VERTICAL IP HOLDINGS, LLC
VERTICAL IP HOLDINGS, LLC

Representatives

Michael B. Chesal Peretz Chesal & Herrmann, P.L.

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

non-medicated acne treatment preparations

Publications

History of USPTO decisions and trademark events.

31 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/03/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/19/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/19/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/19/2022

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

04/18/2022

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

01/21/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/21/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

08/11/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/09/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/14/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/14/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/14/2017

E815

TEAS SECTION 8 & 15 RECEIVED

08/09/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

08/09/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/05/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

07/03/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/30/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/14/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/14/2011

IUAF

USE AMENDMENT FILED

06/07/2011

EISU

TEAS STATEMENT OF USE RECEIVED

06/07/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/07/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/12/2010

PUBO

PUBLISHED FOR OPPOSITION

10/12/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/09/2010

ALIE

ASSIGNED TO LIE

09/09/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/27/2010

DOCK

ASSIGNED TO EXAMINER

08/27/2010

MPMK

NOTICE OF PSEUDO MARK MAILED

05/20/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/19/2010

NWAP

NEW APPLICATION ENTERED

05/18/2010

Continuous trademark protection

Get notified about every new filing that threatens CLEARTHERAPY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.